Immucell Corp (ICCC) Reports Q4 Loss of $0.15

Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of ($0.15). Revenue for the quarter came in at $5.09 million.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
• JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight